4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-24-000016
CIK 0000875320other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:20 PM ET
Size
6.5 KB
Accession
0000875320-24-000016
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Award
Common Stock
2024-02-07+1,853→ 11,641 total - Award
Common Stock
2024-02-06+2,950→ 9,788 total
Footnotes (2)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest in installments beginning on 02/10/2024.
- [F2]Restricted stock unit award that vests in installments beginning on 02/17/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:20 PM ET
- Size
- 6.5 KB